Clinical Trial Update: Relapse Prevention Study in Newly Abstinent Smokers [Phase 2]

View source ↗

Summary

A Phase 2 relapse-prevention trial in newly abstinent smokers sponsored by GlaxoSmithKline has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Snippet

Sponsor: GlaxoSmithKline | Conditions: Substance Dependence | Phase 2 | Status: WITHDRAWN